Fate of EPO encourages drug manufacturers to cooperate with anti-doping agencies

Nowadays a lot of drug manufacturers are ready to cooperate with anti-doping agencies in their fight against intake of forbidden products in sports. It sounds strange but this is the reality. In fact, if you look at the fate of EPO, you can comprehend why pharmaceutical companies agree to support efforts of anti-doping officials. EPO is really an effectual remedy for treatment of anemia. Numerous individuals with anemia that have used EPO have been treated. But what do you think while hearing about this medicine? Almost every individual associates this remedy just with doping in sports. This preparation has been abused by the seven-time winner Lance Armstrong that has cheated the whole world. So, EPO is associated just with cheating, disgrace, etc. Looking at this condition, drug manufacturers try to “defend” their medicines from the similar fate. That’s why they cooperate with anti-doping agencies.
Although some drug manufacturers began to collaborate with anti-doping officials earlier, sometimes there were certain problems between them. Anti-doping officials criticized certain drug manufacturers for their links to doping.
Nowadays relations between anti-doping agencies and pharmaceutical companies are closer. Drug manufacturers share detailed information about new medications with anti-doping agencies. It is valuable information for development of detection tests for these drugs. While anti-doping officials find out how medicines are manufactured, how they pass into body, how they work in the body, they can introduce more effectual tests for these medications.
For example, the company Roche that developed the medication CERA helped anti-doping agencies to elaborate a detection test for it. Later other drug manufacturers followed the example of Roche. The drug manufacturer GlaxoSmithKline went so far, as it sponsored an anti-doping lab during London Olympics.
While relations between anti-doping agencies and huge drug manufacturers become stronger, smaller drug manufacturers started to cooperate with anti-doping agencies as well. While previously drug manufacturers haven’t desired to discuss about their links to anti-doping agencies openly, now they don’t fear to announce about this aspect.